0001753926-24-001129.txt : 20240618 0001753926-24-001129.hdr.sgml : 20240618 20240618200139 ACCESSION NUMBER: 0001753926-24-001129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240614 FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Francis Knuettel II CENTRAL INDEX KEY: 0001433316 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41964 FILM NUMBER: 241053671 MAIL ADDRESS: STREET 1: 205 NEWBURY ST STREET 2: SUITE 204 CITY: FRAMINGHAM STATE: MA ZIP: 01701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chromocell Therapeutics Corp CENTRAL INDEX KEY: 0001919246 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863335449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 US HIGHWAY ONE CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 BUSINESS PHONE: 9176446313 MAIL ADDRESS: STREET 1: 685 US HIGHWAY ONE CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 4 1 ownership.xml X0508 4 2024-06-14 0 0001919246 Chromocell Therapeutics Corp CHRO 0001433316 Francis Knuettel II C/O CHROMOCELL THERAPEUTICS CORPORATION 4400 ROUTE 9 SOUTH, SUITE 1000 FREEHOLD NJ 07728 0 1 0 0 CEO, Pres., CFO Treas & Secty 0 Stock Options 1.30 2024-06-14 4 A 0 27778 A 2024-06-14 2034-06-14 Common Stock 27778 52778 I Camden Capital LLC Stock Options 1.30 2024-06-14 4 A 0 324000 A 2034-06-14 Common Stock 324000 376778 D On June 14, 2024, Camden Capital LLC was granted stock options to purchase 27,778 shares of common stock at an exercise price of $1.30 per share, which were fully vested. The securities are held by Camden Capital LLC. The Reporting Person, as the manager of Camden Capital LLC, is deemed to be a beneficial owner of these securities. On June 14, 2024, the Reporting Person was granted stock options to purchase 324,000 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years. /s/ Francis Knuettel II 2024-06-18